Norway vs Vietnam: 10_Insured export credit exposures, short term
Norway
17.03 billion BU
in 2025
Vietnam
18.96 billion BU
in 2025
Norway rank
35th
Vietnam rank
33rd
10_Insured export credit exposures, short term over time
- Norway
- Vietnam
How they compare
Vietnam currently reports 18.96 billion BU against 17.03 billion BU in Norway, a difference of 1.93 billion BU.
That makes Vietnam's figure about 1.1 times Norway's.
The two have swapped places 3 times across 21 shared years of data; in 2005 it was Norway ahead.
Norway ranks 35th and Vietnam ranks 33rd of 210 countries.
Across the 3 decades both report, Norway averaged higher in 2 and Vietnam in 1.
Head to head by decade
| Decade | Norway | Vietnam | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.57 billion BU | 1.88 billion BU | 4.69 billion BU | Norway |
| 2010s | 9.42 billion BU | 5.77 billion BU | 3.65 billion BU | Norway |
| 2020s | 15.44 billion BU | 16.27 billion BU | 835.33 million BU | Vietnam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher 10_insured export credit exposures, short term, Norway or Vietnam?
- Vietnam, at 18.96 billion BU against 17.03 billion BU in Norway as of 2025.
- What is the difference in 10_insured export credit exposures, short term between Norway and Vietnam?
- 1.93 billion BU, with Vietnam ahead.
- How many years of comparable data are there for Norway and Vietnam?
- 21 years are reported by both, from 2005 to 2025.
- How do Norway and Vietnam rank globally for 10_insured export credit exposures, short term?
- Norway ranks 35th and Vietnam ranks 33rd of 210 countries.
- Where does this data come from?
- BIS, published as 10_Insured export credit exposures, short term (BU). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
ST refers to insured export credits with credit terms up to and including 12 months, except for transactions involving an insured manufacturing (pre-credit) risk with a risk period of more than 12 months, which are classified as medium/long-term (MLT).